Spinocerebellar ataxia type 7 (SCA7): Widespread brain damage in an adult-onset patient with progressive visual impairments in comparison with an adult-onset patient without visual impairments

Neuropathology and Applied Neurobiology

Volumn 34, Issue 2, 2008, Pages 155-168

  Rub U ^a   Brunt, E R ^b   Seidel, K ^a   Gierga, K ^a   Mooy, C M ^c   Kettner, M ^a   Van Broeckhoven, C ^d,e   Bechmann, I ^a   La Spada, A R ^f   Schols L ^g   Den Dunnen, W ^b   De Vos, R A I ^h   Deller, T ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c Laboratory of Pathology Dordrecht   (Netherlands)

^d DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^e UNIVERSITY OF ANTWERP   (Belgium)

^f UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^g UNIVERSITY OF TÜBINGEN   (Germany)

^h Laboratorium Pathologie Oost Nederland   (Netherlands)

Author keywords

Ataxin 7; Autosomal dominant cerebellar ataxias; Pathoanatomy; Polyglutamine diseases; Spinocerebellar ataxias

Indexed keywords

ATAXIN 7; POLYGLUTAMINE;

ADULT; AGED; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; BRAIN DAMAGE; BRAIN STEM; CEREBELLUM; DIENCEPHALON; DISEASE COURSE; DYSARTHRIA; DYSPHAGIA; FEMALE; GAIT; GENETIC ASSOCIATION; HUMAN; MALE; MENTAL DEFICIENCY; MYELINATED NERVE; NEUROLOGIC DISEASE; NEUROPATHOLOGY; PARKINSONISM; PERCEPTION DEAFNESS; PRIORITY JOURNAL; PUPIL DISEASE; PYRAMIDAL SIGN; RARE DISEASE; SACCADIC EYE MOVEMENT; SMOOTH PURSUIT EYE MOVEMENT; SOMATOSENSORY DISORDER; SPINOCEREBELLAR DEGENERATION; TELENCEPHALON; VISUAL IMPAIRMENT;

EID: 40149107007     PISSN: 03051846     EISSN: 13652990     Source Type: Journal    
DOI: 10.1111/j.1365-2990.2007.00882.x     Document Type: Article

References (65)

1. 1 Ansorge O, Giunti P, Michalik A, Van Broeckhoven C, Harding B, Wood N, Scaravilli F. Ataxin‐7 aggregation and ubiquitination in infantile SCA7 with 180 CAG repeats. Ann Neurol 2004 ; 56: 448–52
2. 2 Benton CS, De Silva R, Rutledge SL, Bohlega S, Ashizawa T, Zoghbi HY. Molecular and clinical studies in SCA‐7 define a broad clinical spectrum and the infantile phenotype. Neurology 1998 ; 51: 1081–6
3. 3 Custer SK, Garden GA, Gill N, Rüb U, Libby RT, Schultz C, Guyenet SJ, Deller T, Westrum LE, Sopher BL, La Spada AR. Bergmann glia expression of polyglutamine expanded ataxin‐7 produces neurodegeneration by impairing glutamate transport. Nat Neurosci 2006 ; 9: 1302–11
4. 4 David G, Abbas N, Stevanin G, Dürr A, Yvert G, Cancel G, Weber C, Imbert G, Saudou F, Antoniou E, Drabkin H, Gemmill R, Giunti P, Benomar A, Wood N, Ruberg M, Agid Y, Mandel JL, Brice A. Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion. Nat Genet 1997 ; 17: 65–70
5. 5 David G, Dürr A, Stevanin G, Cancel G, Abbas N, Benomar A, Belal S, Lebre AS, Abada‐Bendib M, Grid D, Holmberg M, Yahyaoui M, Hentati F, Chkili T, Agid Y, Brice A. Molecular and clinical correlations in autosomal dominant cerebellar ataxia with progressive macular dystrophy (SCA7). Hum Mol Genet 1998 ; 7: 165–70
6. 6 Holmberg M, Duyckaerts C, Dürr A, Cancel G, Gourfinkel‐An I, Damier P, Faucheux B, Trottier Y, Hirsch EC, Agid Y. Spinocerebellar ataxia type 7 (SCA7): a neurodegenerative disorder with neuronal intranuclear inclusions. Hum Mol Genet 1998 ; 7: 913–8
7. 7 Paulson H, Ammache Z. Ataxia and hereditary disorders. Neurol Clin 2001 ; 19: 759–82
8. 8 Cancel G, Duyckaerts C, Holmberg M, Zander C, Yvert G, Lebre AS, Ruberg M, Faucheux B, Agid Y, Hirsch E, Brice A. Distribution of ataxin‐7 in normal human brain and retina. Brain 2000 ; 123: 2519–30
9. 9 Del‐Favero J, Krols L, Michalik A, Theuns J, Lofgren A, Gossens D, Wehnert A, Van den Bossche D, Van Zand K, Backhovens H, Van Regenmorter N, Martin JJ, Van Broeckhoven C. Molecular genetic analysis of autosomal dominant cerebellar ataxia with retinal degeneration (ADCA type II) caused by CAG triplet repeat expansion. Hum Mol Genet 1998 ; 7: 177–86
10. 10 Klockgether T. Ataxias. In Textbook of Clinical Neurology, 2nd edn. Ed. CG Goetz. Philadelphia, PA: Saunders, 2003 ; 741–57
11. 11 Lebre AS, Brice A. Spinocerebellar ataxia 7 (SCA7). Cytogenet Genome Res 2003 ; 100: 154–63
12. 12 Michalik A, Martin JJ, Van Broeckhoven C. Spinocerebellar ataxia type 7 associated with pigmentary retinal dystrophy. Eur J Hum Genet 2004 ; 12: 2–15
13. 13 Schöls L, Bauer P, Schmidt T, Schulte T, Riess O. Autosomal dominant cerebellar ataxias. clinical features, genetics, and pathogenesis. Lancet Neurol 2004 ; 3: 291–304
14. 14 Aleman TS, Cideciyan AV, Volpe NJ, Stevanin G, Brice A, Jacobson SG. Spinocerebellar ataxia type 7 (SCA7) shows a cone‐rod dystrophy phenotype. Exp Eye Res 2002 ; 74: 737–45
15. 15 Jonasson J, Strom AL, Hart P, Brannstrom T, Forsgren L, Holmberg M. Expression of ataxin‐7 in CNS and non‐CNS tissue of normal and SCA7 individuals. Acta Neuropathol 2002 ; 104: 29–37
16. 16 Mauger C, Del‐Favero J, Ceuterick C, Lübke U, Van Broeckhoven C, Martin JJ. Identification and localization of ataxin‐7 in brain and retina of a patient with cerebellar ataxia type II using anti‐peptide antibody. Brain Res Mol Brain Res 1999 ; 74: 35–43
17. 17 Takahashi J, Fujigasaki H, Iwabuchi K, Bruni AC, Uchihara T, El Hachimi KH, Stevanin G, Dürr A, Lebre AS, Trottier Y, De The H, Tanaka J, Hauw JJ, Duyckaerts C, Brice A. PML nuclear bodies and neuronal intranuclear inclusion in polyglutamine diseases. Neurobiol Dis 2003 ; 13: 230–7
18. 18 Takahashi J, Fujigasaki H, Zander C, El Hachimi KH, Stevanin G, Dürr A, Lebre AS, Yvert G, Trottier Y, De The H, Hauw JJ, Duyckaerts C, Brice A. Two populations of neuronal intranuclear inclusions in SCA7 differ in size and promyelocytic leukaemia protein content. Brain 2002 ; 125: 1534–43
19. 19 Gilman S. The spinocerebellar ataxias. Clin Neuropharmacol 2000 ; 23: 296–303
20. 20 Gouw LG, Digre KB, Harris CP, Haines JH, Ptacek LJ. Autosomal dominant cerebellar ataxia with retinal degeneration: clinical, neuropathologic, and genetic analysis of a large kindred. Neurology 1994 ; 44: 1441–7
21. 21 Martin JJ, Van Regemorter N, Del‐Favero J, Löfgren A, Van Broeckhoven C. Spinocerebellar ataxia type 7 (SCA7)–correlations between phenotype and genotype in one large Belgian family. J Neurol Sci 1999 ; 168: 37–46
22. 22 Oh AK, Jacobson KM, Jen JC, Baloh RW. Slowing of voluntary and involuntary saccades: an early sign in spinocerebellar ataxia type 7. Ann Neurol 2001 ; 49: 801–4
23. 23 Abe T, Tsuda T, Yoshida M, Wada Y, Kano T, Itoyama Y, Tamai M. Macular degeneration associated with aberrant expansion of trinucleotide repeat of the SCA7 gene in 2 Japanese families. Arch Ophthalmol 2000 ; 18: 1415–21
24. 24 Jobsis GJ, Weber JW, Barth PG, Keizers H, Baas F, Van Schooneveld MJ, Van Hilten JJ, Troost D, Geesink HH, Bolhuis PA. Autosomal dominant cerebellar ataxia with retinal degeneration (ADCA II): clinical and neuropathological findings in two pedigrees and genetic linkage to 3p12‐p21.1. J Neurol Neurosurg Psychiatry 1997 ; 62: 367–71
25. 25 Rüb U, Brunt ER, Gierga K, Seidel K, Schultz C, Schöls L, Auburger G, Heinsen H, Ippel PF, Glimmerveen WF, Wittebol‐Post D, Arai K, Deller T, De Vos RA. Spinocerebellar ataxia type 7 (SCA7): first report of a systematic neuropathological study of the brain of a patient with a very short expanded CAG‐repeat. Brain Pathol 2005 ; 15: 287–95
26. 26 Smithson KG, MacVicar BA, Hatton GI. Polyethylene glycol embedding: a technique compatible with immunocytochemistry, enzyme histochemistry, histofluorescence and intracellular staining. J Neurosci Methods 1983 ; 7: 27–41
27. 27 Braak H, Rüb U, Del Tredici K. Involvement of precerebellar nuclei in multiple system atrophy. Neuropathol Appl Neurobiol 2003 ; 29: 60–76
28. 28 Rüb U, Brunt ER, Del Turco D, De Vos RA, Gierga K, Paulson H, Braak H. Guidelines for the pathoanatomical examination of the lower brain stem in ingestive and swallowing disorders and its application to a dysphagic spinocerebellar ataxia type 3 patient. Neuropathol Appl Neurobiol 2003 ; 29: 1–13
29. 29 Rüb U, Schultz C, Del Tredici K, Gierga K, Reifenberg G, De Vos RA, Seifried C, Braak H, Auburger G. Anatomically based guidelines for systematic investigation of the central somatosensory system and their application to a spinocerebellar ataxia type 2 (SCA2) patient. Neuropathol Appl Neurobiol 2003 ; 29: 418–33
30. 30 Braak H. Architectonics of the Human Telencephalic Cortex. Berlin: Springer, 1980
31. 31 Brodmann K. Vergleichende Lokalisationslehre der Grosshirnrinde. Leipzig: J.A. Barth, 1909
32. 32 Gilman S. Cerebellum and motor dysfunction. In Diseases of the Nervous System: Clinical Neurobiology, 2nd edn. Eds AK Asbury, GM McKhann, WI McDonald. Philadelphia, PA: Saunders, 1992 ; 368–89
33. 33 Horn AKE. The reticular formation. Prog Brain Res 2006 ; 151: 127–55
34. 34 Jones EG. The Thalamus. New York: Plenum Press, 1985
35. 35 Olszewski J, Baxter D. Cytoarchitecture of the Human Brain Stem. Basel: Karger, 1982
36. 36 Paxinos G. The Human Nervous System. San Diego, CA: Academic Press, 1990
37. 37 Rüb U, Gierga K, Brunt ER, De Vos RA, Bauer M, Schöls L, Bürk K, Auburger G, Bohl J, Schultz C, Vuksic M, Burbach GJ, Braak H, Deller T. Spinocerebellar ataxias types 2 and 3: degeneration of the pre‐cerebellar nuclei isolates the three phylogenetically defined regions of the cerebellum. J Neural Transm 2005 ; 112: 1523–45
38. 38 Zilles K. Cortex. In The Human Nervous System. Ed. G Paxinos. San Diego, CA: Academic Press, 1990 ; 757–802
39. 39 Hutchins B, Weber JT. A rapid myelin stain for frozen sections: modification of the Heidenhain procedure. J Neurosci Methods 1983 ; 7: 289–94
40. 40 Riley HA. An Atlas of the Basal Ganglia, Brain Stem and Spinal Cord Based on Myelin‐Stained Material. Baltimore, MD: Williams & Wilkins, 1943
41. 41 Gierga K, Bürk K, Bauer M, Orozco Diaz G, Auburger G, Schultz C, Vuksic M, Schöls L, De Vos RA, Braak H, Deller T, Rüb U. Involvement of the cranial nerves and their nuclei in spinocerebellar ataxia type 2 (SCA2). Acta Neuropathol 2005 ; 109: 617–31
42. 42 Rüb U, Brunt ER, De Vos RA, Del Turco D, Del Tredici K, Gierga K, Schultz C, Ghebremedhin E, Bürk K, Auburger G, Braak H. Degeneration of the central vestibular system in spinocerebellar ataxia type 3 patients and its possible clinical significance. Neuropathol Appl Neurobiol 2004 ; 30: 402–14
43. 43 Rüb U, Bürk K, Schöls L, Brunt ER, De Vos RA, Diaz GO, Gierga K, Ghebremedhin E, Schultz C, Del Turco D, Mittelbronn D, Auburger G, Deller T, Braak H. Damage to the reticulotegmental nucleus of the pons in spinocerebellar ataxia type 1, 2, and 3. Neurology 2004 ; 63: 1258–63
44. 44 Rüb U, Del Turco D, Del Tredici K, De Vos RA, Brunt ER, Reifenberger G, Seifried C, Schultz C, Auburger G, Braak H. Thalamic involvement in a spinocerebellar ataxia type 2 (SCA2) and a spinocerebellar ataxia type 3 (SCA3) patient, and its clinical relevance. Brain 2003 ; 126: 2257–72
45. 45 Rüb U, De Vos RA, Brunt ER, Schultz C, Paulson H, Del Tredici K, Braak H. Degeneration of the external cuneate nucleus in spinocerebellar ataxia type 3 (Machado‐Joseph disease). Brain Res 2002 ; 953: 126–34
46. 46 Rüb U, De Vos RA, Schultz C, Paulson H, Brunt ER, Braak H. Spinocerebellar ataxia type 3 (Machado‐Joseph disease): severe destruction of the lateral reticular nucleus. Brain 2002 ; 125: 2115–24
47. 47 Rüb U, Seidel K, Özerden I, Gierga K, Brunt ER, Schöls L, De Vos RA, Den Dunnen W, Schultz C, Auburger G, Deller T. Consistent affection of the central somatosensory system in spinocerebellar ataxia type 2 and type 3 and its significance for clinical symptoms and rehabilitative therapy. Brain Res Brain Res Rev 2007 ; 53: 235–49
48. 48 Alexander GE, DeLong NR. Central mechanisms of initiation and control of movement. In Diseases of the Nervous System: Clinical Neurobiology, 2nd edn. Eds AK Asbury, GM McKhann, WI McDonald. Philadelphia, PA: Saunders, 1992 ; 285–308
49. 49 Zeffiro TA. Motor cortex. In The Human Nervous System. Ed. G Paxinos. San Diego, CA: Academic Press, 1990 ; 803–81
50. 50 Alexander GE, Crutcher MD, DeLong MR. Basal ganglia‐thalamocortical circuits: parallel substrates for motor, oculomotor, ‘prefrontal’ and ‘limbic’ functions. Prog Brain Res 1990 ; 85: 119–46
51. 51 Lindblom U, Ochoa J. Somatosensory function and dysfunction. In Diseases of the Nervous System: Clinical Neurobiology, 2nd edn. Eds AK Asbury, GM McKhann, WI McDonald. Philadelphia, PA: Saunders, 1992 ; 213–28
52. 52 Chiappa KH. Evoked Potentials in Clinical Medicine, 3rd edn. Philadelphia, PA: Lippincott, Williams & Wilkins Publishers, 1997
53. 53 White CT, White CL, Hintze RW. Cortical and subcortical components of the pattern VEP. Int J Neurosci 1983 ; 19: 125–32
54. 54 Leigh RJ, Kennard C. Using saccades as a research tool in the clinical neuroscience. Brain 2004 ; 127: 460–77
55. 55 Leigh RJ, Zee DS. The Neurology of Eye Movements, 2nd edn. Philadelphia, PA: Davis Company, 1991
56. 56 Biacabe B, Chevallier JM, Avan P, Bonfils P. Functional anatomy of auditory brainstem nuclei: application to the anatomical basis of brainstem auditory evoked potentials. Auris Nasus Larynx 2001 ; 28: 85–94
57. 57 Møller AR. Neural mechanisms of BAEP. In Functional Neuroscience: Evoked Potentials and Magnetic Fields. Eds C Barber, CG Celesia, I Hashimoto, R Kakigi. Amsterdam: Elsevier Science, 1999 ; 27–35
58. 58 Webster WR, Garey LJ. Auditory system. In The Human Nervous System. Ed. G Paxinos. San Diego, CA: Academic Press, 1990 ; 889–944
59. 59 Barmack NH. Central vestibular system and posterior cerebellum. Brain Res Bull 2003 ; 60: 511–41
60. 60 Gerrits NM. Vestibular nuclear complex. In The Human Central Nervous System. Ed. G Paxinos. San Diego, CA: Academic Press, 1990 ; 863–88
61. 61 Waybright EA, Gutmann L, Chou SM. Facial myokymia. Pathological features. Arch Neurol 1979 ; 36: 244–5
62. 62 Kaas JH. Somatosensory system. In The Human Nervous System. Ed. G Paxinos. San Diego, CA: Academic Press, 1990 ; 813–44
63. 63 Grieve KL, Acuña C, Cudeiro J. The primate pulvinar nuclei: vision and action. Trends Neurosci 2000 ; 23: 35–9
64. 64 Robinson DL, Petersen SE. The pulvinar and visual salience. Trends Neurosci 1992 ; 15: 127–32
65. 65 Büttner U, Büttner‐Ennever JA. Present concepts of oculomotor organization. Prog Brain Res 2006 ; 151: 1–42